ALEXANDRIA, Va., March 24 -- United States Patent no. 12,584,116, issued on March 24, was assigned to CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (Spain).

"Attenuated variant of the rift valley fever virus, composition comprising same, and uses thereof" was invented by Alejandro Brun Torres (Madrid), Maria Belen Borrego Rivero (Madrid) and Sandra Moreno Fernandez (Madrid).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to an attenuated variant of the Rift Valley Fever Virus (RVFV) with mutations in the amino acid sequence coded by segments L, M and S of RVFV RNA; a pharmaceutical or veterinary composition comprising same; an attenuated RVFV variant for use in the prevention of ...